SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-22-006902
Filing Date
2022-11-25
Accepted
2022-11-25 19:05:26
Documents
1
Period of Report
2022-11-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7877
  Complete submission text file 0000919574-22-006902.txt   9828
Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Reporting) CIK: 0001534261 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 221420937

Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Business Address
Casdin Eli (Reporting) CIK: 0001534264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 221420938

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)